Netflix and Warner Bros. to Defend Proposed Deal Before Skeptical Regulatory Panel
Read Our Expert Analysis
Create an account or login for free to unlock our expert analysis and key takeaways for this development.
By continuing, you agree to receive marketing communications and our weekly newsletter. You can opt-out at any time.
Recommended for you

Paramount ups the ante to block Netflix’s $83B takeover of Warner Bros. Discovery
Paramount sweetened its hostile $30-per-share all-cash bid for Warner Bros. Discovery by adding contingent cash protections — roughly $650 million per quarter beginning in 2027 and a pledge to cover a $2.8 billion breakup fee — in a bid to undercut Netflix’s roughly $83 billion offer. Heightened regulatory scrutiny of the Netflix-WBD transaction makes those protections more salient, but investor confidence and the final outcome remain uncertain ahead of a shareholder vote in late March or early April.

Ellison’s White House Visit Escalates Battle Over Warner Bros. Discovery Deal
Paramount CEO David Ellison’s private Oval Office meeting with President Trump has injected political optics into a fierce takeover struggle for Warner Bros. Discovery, even as Paramount sweetens its $30-per-share bid with contingent cash payments and a pledge to assume a $2.8 billion termination fee. The developments complicate regulatory scrutiny of Netflix’s rival offer — including a DOJ inquiry and an upcoming regulatory panel — and leave shareholders weighing price against legal and timing risk.
Broadcasters and Newsmax Face Senate Hearing Over 39% National TV Ownership Cap
Broadcasters’ trade group and Newsmax will appear before the U.S. Senate Commerce Committee to argue opposite positions on a rule that limits national television reach to roughly 39% of U.S. TV households. Proponents frame the cap as a safeguard for competition and viewpoint variety, while industry advocates say the restriction is outdated and undermines broadcasters’ ability to compete for audiences and advertising.
UK regulators open probe into DMGT’s £500m bid for Telegraph amid plurality concerns
The UK government has ordered a formal examination of the proposed £500m acquisition of the Telegraph by Daily Mail and General Trust, citing worries about media plurality and competition. The Competition and Markets Authority and Ofcom have been asked to assess competition and public-interest implications and to report back by 10 June.

Live Nation Faces State-Led Push for Antitrust Trial Despite DOJ Settlement Talks
Multiple state attorneys general, led by California and Connecticut, are prepared to force an antitrust trial aiming at structural remedies for Live Nation even if the federal government negotiates a settlement. California Attorney General Rob Bonta says states will pursue a case unless any deal satisfies strict standards for restoring competition.

Apple and Google Commit to App‑Store Overhaul After UK Regulator Steps In
Britain’s competition authority has secured binding commitments from Apple and Google to make their mobile app marketplaces more transparent and to open selected platform capabilities to outside developers. The move aims to boost competition and developer choice, but its real effect will hinge on how the changes are implemented and enforced without undermining user safety.
Blue Ant secures regulatory and court approvals to finalize acquisition of Thunderbird
Blue Ant obtained the necessary provincial court authorization and clearance from Canada’s competition authority to proceed with buying Thunderbird. The company expects the transaction to close this month, subject to routine closing conditions, positioning Blue Ant to expand its content and streaming capabilities.
Warren and Hawley Push to Break Up Vertically Integrated Health Giants
Two senators from opposite sides of the aisle introduced legislation to bar large health firms from owning both care providers and entities that set prices, aiming to reduce conflicts of interest and boost competition. The bill would empower federal agencies to enforce divestitures and levy penalties, setting up a major legal and political fight with insurers, PBMs and pharmacy chains.